Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Acadia Pharmaceuticals’s reported figures.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
FAQ
- What is Acadia Pharmaceuticals's EBIT?
- Acadia Pharmaceuticals (ACAD) reported EBIT of $37.84M in Q2 2026.
- How has Acadia Pharmaceuticals's EBIT changed year-over-year?
- Acadia Pharmaceuticals's EBIT increased by 16.9% year-over-year, from $32.37M to $37.84M.
- What is the long-term trend for Acadia Pharmaceuticals's EBIT?
- Over 3 years (2021 to 2025), Acadia Pharmaceuticals's EBIT has grown at a -15.0% compound annual growth rate (CAGR), from -$170.44M to $104.81M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Acadia Pharmaceuticals's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude